MintNeuro: Venture Capital Funding History
MintNeuro
To add a bio or update company history, please click update information.
News from MintNeuro


MintNeuro
7 Oct 2026
MintNeuro lands a £4m seed round led by Odyssey Ventures for semiconductor chips that connect devices directly with the brain
MintNeuro develops specialised semiconductor chips that are purpose-built to operate inside the human body and connect devices with the brain and nervous system. MintNeuro enables developers of neural implants and other medical devices to avoid trade-offs between generic components and lengthy custom chip development.


MintNeuro
12 Nov 2024
Imperial spinout MintNeuro raises £1m to advance neural implants with semiconductor technology
MintNeuro develops compact semiconductor-based neural implants that reduce the invasiveness and power demands of traditional devices, supporting scalable neuromodulation treatments for conditions including epilepsy, Parkinson’s and dementia.
MintNeuro
- Life Sciences
- London, United Kingdom
- £5m
- mintneuro.com
- Update Information
More venture news
- 13 Nov 2026

Oyster TherapeuticsOyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
Series ALife Sciences - 10 Nov 2026

Neobe TherapeuticsNeobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
SeedLife Sciences - 9 Nov 2026

PhaSER BiomedicalPhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
GrantLife Sciences